These 3 Cruise Stocks are Buy Opportunities – 8/1

The pullback in cruise stocks is a buying opportunity.

Company: Royal Caribbean (SYM: RCL)

Look at Royal Caribbean (SYM: RCL), for example.

Even with strong earnings growth, the stock dropped.

However, not only did it just catch support at its 50-day moving average, but it’s also excessively oversold on RSI and Williams’ %R. 

Helping, RCL just raised its adjusted earnings per share outlook to a new range of $11.35 to $11.45 from an older range of $10.70 to $10.90. The company even reinstated a 40-cent dividend, which is payable on Oct. 11. That, coupled with explosive demand makes Royal Caribbean a strong buy at current prices.

rcl

Millionaire Publishing

Make this simple trade at 2:59pm on Friday! (Grab it now)

tim video

Make this one simple trade at 2:59pm on Friday afternoon…

And you’ll thank me on Monday morning.

These few simple moves today could make 2024 your year of financial triumph!


>>>Click here to get the details on the trade.

Company: Carnival (SYM: CCL)

Or, look at Carnival (SYM: CCL). 

Oversold, Carnival recently beat its EPS estimates again. Plus, in its recent report, it said company bookings are at record highs this year and are significantly exceeding 2023 numbers. 

Even better, the company saw customer deposits hit a record high of $8.3 billion in the second quarter, which was $1.1 billion higher than a prior record high.

Financial Markets Daily

Small biotech firm is working on the next revolutionary antiviral medicine

biotech

This innovative biotech company is taking a novel, game-changing approach to eradicating many respiratory viruses including the tripledemic threat of COVID, RSV, and the FLU!

As a global leader in broad-spectrum antiviral nanomedicines developing drugs that work safely and effectively even against variants.

Learn more about how NV-387 may become the next revolutionary antiviral medicine.

Company: Norwegian Cruise Line (SYM: NCLH)

Also oversold, Norwegian Cruise Line (SYM: NCLH) just beat top and bottom line estimates. EPS of 40 cents beat by six cents. Revenue of $2.4 billion, up 8.6% year over year beat by $20 million. Adjusted EBITDA jumped 14% to $587.7 million. 

NCLH also raised its full-year adjusted net income guidance by $60 million to about $790 million from $730 million. It also increased its adjusted EPS guidance to $1.53 from $1.43.

It’s just something to consider if you’re looking for opportunities in this crazy market.

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Categories

Recent posts

Tags

Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.